Jim O’Neill steps in as acting CDC director, replacing Susan Monarez amid controversy over vaccine policies. With ties to RFK Jr. and a libertarian stance, will he advocate for public health or follow orders?
CVS has announced major changes to COVID vaccine availability, offering shots in 34 states and requiring prescriptions in 13 others, leaving many Americans confused amid a new variant surge.
In a surprising turn of events, the White House has named a new acting head for the CDC after significant departures linked to vaccine policy disagreements. Who is stepping in?
In a dramatic shakeup, Jim O'Neill has been appointed as the acting director of the CDC following the ousting of Susan Monarez. This transition comes amidst widespread resignations and controversy surrounding the agency's leadership and vaccine policies.
In a major shift, the FDA has approved updated Covid boosters while restricting access for children under 5, raising concerns among parents and health experts. Learn about the new guidelines and their implications.
In a controversial 5-4 ruling, the Supreme Court temporarily halted $783 million in NIH research grants, igniting debates over the Trump administration's funding cuts and the implications for scientific research.
In a controversial move, D.C. officials gave residents of a homeless encampment only one day's notice to vacate as part of a broader crackdown initiated by the Trump administration. This action has sparked outrage and concern over treatment of vulnerable populations.
Health and Human Services Secretary Robert F. Kennedy Jr. is reportedly planning to dismiss members of the U.S. Preventive Services Task Force, alarming medical experts and organizations about the potential risks to preventive healthcare standards.
In a surprising move, Health Secretary Robert F. Kennedy Jr. has dismissed two senior deputies, marking a significant leadership change at the Department of Health and Human Services. This decision reflects Kennedy's strategic vision for the agency's future.
In a surprising turn of events, Dr. Michael Ross has withdrawn from the vaccine advisory panel after a conflict of interest review revealed ties to private healthcare companies. This comes amidst ongoing scrutiny of the committee’s integrity.
